Benjamin T Dake is of Aerovate Therapeutics, Inc.. Currently has a direct ownership of 14,252 shares of AVTE, which is worth approximately $37,910. The most recent transaction as insider was on Aug 07, 2023, when has been sold 10,283 shares (Common Stock) at a price of $1.94 per share, resulting in proceeds of $19,949. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.3K
0% 3M change
1003.95% 12M change
Total Value Held $37,910

Benjamin T Dake Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 07 2023
BUY
Exercise of conversion of derivative security
$19,949 $1.94 p/Share
10,283 Added 47.05%
11,574 Common Stock
Jul 06 2023
SELL
Open market or private sale
$171,314 $16.66 p/Share
10,283 Reduced 88.85%
1,291 Common Stock
Jul 06 2023
BUY
Exercise of conversion of derivative security
$19,949 $1.94 p/Share
10,283 Added 47.05%
11,574 Common Stock
Jun 06 2023
SELL
Open market or private sale
$171,006 $16.63 p/Share
10,283 Reduced 88.85%
1,291 Common Stock
Jun 06 2023
BUY
Exercise of conversion of derivative security
$19,949 $1.94 p/Share
10,283 Added 47.05%
11,574 Common Stock
May 08 2023
SELL
Open market or private sale
$228,099 $22.18 p/Share
10,284 Reduced 88.85%
1,291 Common Stock
May 08 2023
BUY
Exercise of conversion of derivative security
$19,950 $1.94 p/Share
10,284 Added 47.05%
11,575 Common Stock
Apr 06 2023
SELL
Open market or private sale
$186,842 $18.17 p/Share
10,283 Reduced 100.0%
0 Common Stock
Apr 06 2023
BUY
Exercise of conversion of derivative security
$19,949 $1.94 p/Share
10,283 Added 50.0%
10,283 Common Stock
Mar 06 2023
SELL
Open market or private sale
$247,899 $24.11 p/Share
10,282 Reduced 100.0%
0 Common Stock
Mar 06 2023
BUY
Exercise of conversion of derivative security
$19,947 $1.94 p/Share
10,282 Added 50.0%
10,282 Common Stock
Feb 06 2023
SELL
Open market or private sale
$254,734 $24.77 p/Share
10,284 Reduced 100.0%
0 Common Stock
Feb 06 2023
BUY
Exercise of conversion of derivative security
$19,950 $1.94 p/Share
10,284 Added 50.0%
10,284 Common Stock
Jan 06 2023
SELL
Open market or private sale
$270,366 $26.29 p/Share
10,284 Reduced 100.0%
0 Common Stock
Jan 06 2023
BUY
Exercise of conversion of derivative security
$19,950 $1.94 p/Share
10,284 Added 50.0%
10,284 Common Stock
Dec 12 2022
SELL
Open market or private sale
$58,269 $28.3 p/Share
2,059 Reduced 100.0%
0 Common Stock
Dec 12 2022
BUY
Exercise of conversion of derivative security
$4,406 $2.14 p/Share
2,059 Added 50.0%
2,059 Common Stock
Dec 09 2022
SELL
Open market or private sale
$9,861 $25.03 p/Share
394 Reduced 100.0%
0 Common Stock
Dec 09 2022
BUY
Exercise of conversion of derivative security
$843 $2.14 p/Share
394 Added 50.0%
394 Common Stock
Dec 08 2022
SELL
Open market or private sale
$223,000 $22.3 p/Share
10,000 Reduced 100.0%
0 Common Stock
Dec 08 2022
BUY
Exercise of conversion of derivative security
$21,400 $2.14 p/Share
10,000 Added 50.0%
10,000 Common Stock
Dec 06 2022
SELL
Open market or private sale
$686,000 $17.15 p/Share
40,000 Reduced 100.0%
0 Common Stock
Dec 06 2022
BUY
Exercise of conversion of derivative security
$77,600 $1.94 p/Share
40,000 Added 50.0%
40,000 Common Stock
Nov 11 2022
SELL
Open market or private sale
$132,203 $21.33 p/Share
6,198 Reduced 100.0%
0 Common Stock
Nov 11 2022
BUY
Exercise of conversion of derivative security
$13,263 $2.14 p/Share
6,198 Added 50.0%
6,198 Common Stock
BTD

Benjamin T Dake

Waltham,, MA

Track Institutional and Insider Activities on AVTE

Follow Aerovate Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTE shares.

Notify only if

Insider Trading

Get notified when an Aerovate Therapeutics, Inc. insider buys or sells AVTE shares.

Notify only if

News

Receive news related to Aerovate Therapeutics, Inc.

Track Activities on AVTE